Form 4: Columbia Financial CEO Boosts Stake via Deferral Plan
Insider Transaction Report
Columbia Financial's President & CEO, Thomas J. Kemly, acquired additional common stock through a non-discretionary deferral plan, increasing his indirect beneficial ownership.
Summary
- Thomas J. Kemly, President & CEO and Director of Columbia Financial, Inc. (CLBK), acquired 115.2244 shares of common stock on September 19, 2025, at a price of $15.51 per share.
- The acquisition was made through the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan, where phantom stock was purchased by the trustee of the Bank's rabbi trust.
- Following this transaction, Mr. Kemly's total beneficial ownership of common stock is 576,933.89 shares, held directly and indirectly through various plans and accounts.
- Mr. Kemly also holds 826,282 derivative securities in the form of stock options, with exercise prices ranging from $15.60 to $16.49 and expiration dates between 2029 and 2035.
- A significant portion of Mr. Kemly's equity holdings, including stock awards and options, are subject to future vesting schedules, some tied to performance-based criteria and others to time-based installments.
Sentiment
Score: 7
Explanation: The acquisition of shares by the President & CEO, even if non-discretionary, signals continued alignment of management interests with shareholders and confidence in the company's long-term prospects. This is generally viewed as a positive indicator.
Positives
- The acquisition of additional common stock by the President & CEO, even if non-discretionary, signals continued alignment of management interests with shareholders.
- A substantial portion of the CEO's compensation is tied to company performance and stock value through various equity incentive plans, promoting long-term commitment.
Future Outlook
A significant portion of the CEO's equity compensation, including stock awards and options, is subject to future vesting. These vest over several years, with some commencing as early as May 1, 2024, and others tied to performance criteria that, if achieved, would vest three years after the award date, such as March 3, 2028, for Stock Award IV.
Industry Context
This filing is a standard disclosure of an insider transaction and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual executive's equity holdings and compensation structure within the financial services sector.
Related Party Transactions
- The acquisition of shares was made through the Columbia Bank Stock Based Deferral Plan, a non-qualified plan maintained in connection with Columbia Bank, a subsidiary of Columbia Financial, Inc. This represents a transaction with a related entity as part of executive compensation.
Stakeholder Impact
- Shareholders: The transaction demonstrates management's continued equity stake and alignment with shareholder interests, potentially fostering confidence.
- Employees: The existence of various equity incentive plans (e.g., 401(k), ESOP, Stock Awards) indicates a structured approach to employee and executive compensation, which can impact morale and retention.
Next Steps
- Continued vesting of stock awards and options according to their respective schedules, with key vesting dates in May 2024, March 2025, March 2026, and March 2028.
- Settlement of stock unit interests under the Columbia Bank Stock Based Deferral Plan in shares of stock upon distribution to the reporting person.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date when 656,471 stock options with an exercise price of $15.60 became fully vested and exercisable. |
| 05/01/2024 | Commencement date for the first of three approximately equal annual installments for vesting of certain stock awards (Stock Award II) and 37,894 stock options. |
| 03/06/2025 | Commencement date for the first of three approximately equal annual installments for vesting of certain stock awards (Stock Award III) and 37,168 stock options. |
| 09/19/2025 | Date of the reported transaction where 115.2244 shares of common stock were acquired. |
| 03/03/2026 | Commencement date for the first of three approximately equal annual installments for vesting of 94,749 stock options. |
| 03/03/2028 | Vesting date for Stock Award IV, contingent upon achievement of specified performance-based criteria. |
| 07/23/2029 | Expiration date for 656,471 fully vested stock options. |
| 05/01/2033 | Expiration date for 37,894 stock options. |
| 03/06/2034 | Expiration date for 37,168 stock options. |
| 03/03/2035 | Expiration date for 94,749 stock options. |
| 09/23/2025 | Signature date of the reporting person's power of attorney. |
Recommendation
holdThe filing indicates a routine acquisition of shares by the President & CEO through a non-discretionary deferral plan, which is a positive signal of management's alignment with shareholder interests. However, it does not present new fundamental information about the company's financial performance or strategic direction that would warrant a change from a 'hold' position based solely on this filing. Investors should consider broader financial reports and market conditions for a comprehensive assessment.
Keywords
Columbia Financial, CLBK, Insider Trading, Form 4, Stock Acquisition, Executive Compensation, Stock Options, Equity Incentive Plan, Thomas J. Kemly, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.